Medicare AdvantagePrior AuthMedium impact
Orencia (abatacept) Intravenous (Revised)
Humana·Rheumatology, Internal Medicine·Medicare Advantage
We identified it
Jul 22, 2026
Summary
Humana Medicare Advantage has revised its Prior Authorization policy for Orencia (abatacept) Intravenous. This is a summary-only document, and the specific clinical criteria, authorization requirements, and any billing/coverage changes are not detailed in the available content. The billing team must obtain the full policy document to understand what changed and implement necessary workflow updates.
Action Required
Immediately: Billing team must access the full policy document at https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a58683c to determine specific prior authorization requirements for Orencia IV claims. Do not rely on older policy versions. Once the full policy is reviewed, update billing system rules, encounter forms, and provider communication templates to reflect new authorization processes. Any Orencia IV claims submitted without compliance to the revised requirements will be denied. Clinical staff and providers must be notified of any changes to documentation or medical necessity criteria.